Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick L Beijersbergen

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Molecular Cell|April 13, 2021
Impact of chromatin context on Cas9-induced DNA double-strand break repair pathway balanceRuben Schep, Eva K Brinkman, Christ Leemans, et al.
Blood|May 29, 2026
DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell LymphomaCamiel Göbel, Rachele Niccolai, Sebastian Gregoricchio, et al.
Molecular Cell|December 13, 2005
Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cellsBarbara Nicke, Julie Bastien, Sophia J Khanna, et al.
Cancer Research|April 17, 2019
Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (<i>ATR</i>) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal CancerEve Combès, Augusto F Andrade, Diego Tosi, et al.
Genome Medicine|October 19, 2021
Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancerYuchen Guo, Jun Wang, Bente Benedict, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulatorAnniek Zaalberg, Emma Minnee, Isabel Mayayo-Peralta, et al.
Neoplasia (New York, N.Y.)|October 28, 2025
Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibitionRachele Niccolai, Camiel Göbel, Klevis Ndoj, et al.
Cancer Cell|October 16, 2007
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancerKatrien Berns, Hugo M Horlings, Bryan T Hennessy, et al.
Cancer Immunology Research|February 8, 2023
Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic CellsEsmée P Hoefsmit, Paula T van Royen, Disha Rao, et al.
Oncogene|May 16, 2018
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitorsKatrien Berns, Joseph J Caumanns, E Marielle Hijmans, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Molecular Cell|April 13, 2021
Impact of chromatin context on Cas9-induced DNA double-strand break repair pathway balanceRuben Schep, Eva K Brinkman, Christ Leemans, et al.
Blood|May 29, 2026
DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell LymphomaCamiel Göbel, Rachele Niccolai, Sebastian Gregoricchio, et al.
Molecular Cell|December 13, 2005
Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cellsBarbara Nicke, Julie Bastien, Sophia J Khanna, et al.
Cancer Research|April 17, 2019
Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (<i>ATR</i>) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal CancerEve Combès, Augusto F Andrade, Diego Tosi, et al.
Genome Medicine|October 19, 2021
Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancerYuchen Guo, Jun Wang, Bente Benedict, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulatorAnniek Zaalberg, Emma Minnee, Isabel Mayayo-Peralta, et al.
Neoplasia (New York, N.Y.)|October 28, 2025
Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibitionRachele Niccolai, Camiel Göbel, Klevis Ndoj, et al.
Cancer Cell|October 16, 2007
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancerKatrien Berns, Hugo M Horlings, Bryan T Hennessy, et al.
Cancer Immunology Research|February 8, 2023
Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic CellsEsmée P Hoefsmit, Paula T van Royen, Disha Rao, et al.
Oncogene|May 16, 2018
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitorsKatrien Berns, Joseph J Caumanns, E Marielle Hijmans, et al.
Pageof 10